Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 23% ± 9% | |
| fibroblast | 14 studies | 22% ± 7% | |
| astrocyte | 11 studies | 32% ± 13% | |
| adipocyte | 8 studies | 27% ± 10% | |
| oligodendrocyte | 8 studies | 25% ± 7% | |
| oligodendrocyte precursor cell | 8 studies | 30% ± 11% | |
| macrophage | 8 studies | 27% ± 6% | |
| classical monocyte | 7 studies | 19% ± 3% | |
| type I pneumocyte | 7 studies | 29% ± 10% | |
| glutamatergic neuron | 6 studies | 44% ± 20% | |
| microglial cell | 6 studies | 25% ± 7% | |
| epithelial cell | 6 studies | 42% ± 18% | |
| type II pneumocyte | 6 studies | 26% ± 7% | |
| GABAergic neuron | 6 studies | 38% ± 19% | |
| interneuron | 6 studies | 37% ± 20% | |
| mucosal invariant T cell | 5 studies | 18% ± 1% | |
| myeloid cell | 5 studies | 24% ± 4% | |
| dendritic cell | 5 studies | 21% ± 6% | |
| monocyte | 5 studies | 27% ± 7% | |
| club cell | 5 studies | 27% ± 9% | |
| basal cell | 5 studies | 30% ± 18% | |
| neutrophil | 4 studies | 23% ± 7% | |
| squamous epithelial cell | 4 studies | 44% ± 18% | |
| non-classical monocyte | 4 studies | 20% ± 3% | |
| neuron | 4 studies | 26% ± 10% | |
| natural killer cell | 4 studies | 17% ± 1% | |
| cardiac muscle cell | 4 studies | 25% ± 3% | |
| ciliated cell | 4 studies | 26% ± 12% | |
| lymphocyte | 4 studies | 23% ± 3% | |
| muscle cell | 4 studies | 26% ± 10% | |
| endothelial cell of lymphatic vessel | 4 studies | 23% ± 5% | |
| smooth muscle cell | 4 studies | 19% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 3% | |
| retinal pigment epithelial cell | 3 studies | 28% ± 13% | |
| mesothelial cell | 3 studies | 21% ± 1% | |
| Mueller cell | 3 studies | 26% ± 4% | |
| hepatocyte | 3 studies | 43% ± 23% | |
| abnormal cell | 3 studies | 25% ± 12% | |
| ependymal cell | 3 studies | 31% ± 13% | |
| adventitial cell | 3 studies | 17% ± 2% | |
| alveolar macrophage | 3 studies | 28% ± 9% | |
| pericyte | 3 studies | 24% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5878.50 | 1445 / 1445 | 100% | 84.31 | 183 / 183 |
| lung | 100% | 5141.78 | 578 / 578 | 100% | 104.37 | 1155 / 1155 |
| ovary | 100% | 4663.29 | 180 / 180 | 100% | 78.90 | 430 / 430 |
| prostate | 100% | 3834.97 | 245 / 245 | 100% | 79.37 | 502 / 502 |
| stomach | 100% | 3261.30 | 359 / 359 | 100% | 68.19 | 286 / 286 |
| brain | 100% | 3910.72 | 2638 / 2642 | 100% | 115.34 | 705 / 705 |
| breast | 100% | 4548.92 | 459 / 459 | 100% | 83.62 | 1116 / 1118 |
| bladder | 100% | 4556.71 | 21 / 21 | 100% | 73.74 | 503 / 504 |
| intestine | 100% | 3915.24 | 966 / 966 | 100% | 70.08 | 525 / 527 |
| uterus | 100% | 4308.65 | 170 / 170 | 100% | 89.10 | 457 / 459 |
| kidney | 100% | 3707.90 | 89 / 89 | 100% | 70.58 | 897 / 901 |
| thymus | 100% | 3336.32 | 652 / 653 | 100% | 72.91 | 602 / 605 |
| liver | 100% | 2845.31 | 226 / 226 | 99% | 54.54 | 403 / 406 |
| skin | 100% | 4387.78 | 1808 / 1809 | 99% | 53.23 | 468 / 472 |
| adrenal gland | 100% | 6335.39 | 258 / 258 | 99% | 64.28 | 227 / 230 |
| pancreas | 97% | 1642.04 | 317 / 328 | 100% | 82.16 | 178 / 178 |
| adipose | 100% | 4557.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4656.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 63.47 | 29 / 29 |
| muscle | 100% | 7647.76 | 803 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 8899.50 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3361.13 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 94.55 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 33.37 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 50.83 | 79 / 80 |
| heart | 96% | 2940.02 | 829 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0036258 | Biological process | multivesicular body assembly |
| GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
| GO_0043328 | Biological process | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
| GO_0090148 | Biological process | membrane fission |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0010008 | Cellular component | endosome membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0000813 | Cellular component | ESCRT I complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0043130 | Molecular function | ubiquitin binding |
| Gene name | UBAP1 |
| Protein name | Ubiquitin associated protein 1 Ubiquitin-associated protein 1 (UBAP-1) (Nasopharyngeal carcinoma-associated gene 20 protein) |
| Synonyms | NAG20 |
| Description | FUNCTION: Component of the ESCRT-I complex, a regulator of vesicular trafficking process . Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs) . Plays a role in the proteasomal degradation of ubiquitinated cell-surface proteins, such as EGFR and BST2 . . |
| Accessions | A0A6G6AA68 ENST00000359544.2 [Q9NZ09-1] ENST00000625521.2 [Q9NZ09-4] ENST00000297661.9 [Q9NZ09-1] ENST00000379186.8 [Q9NZ09-2] A0A0D9SG79 ENST00000626262.2 Q9NZ09 |